Monday, December 23, 2024
HomeTagsCMS

CMS

Endologix announces the U. S. Centers for Medicare & Medicaid Services granted a Transitional Pass-Through (TPT) Payment for the DETOUR™ System

Endologix LLC, a privately held, global medical device company dedicated to providing disruptive therapies for the interventional treatment of vascular disease, announces that the...

GRAIL To Initiate REACH Study To Evaluate Clinical Impact Of GalleriⓇ Multi-Cancer Early Detection (MCED) Test Among The Medicare Population

Prospective, Multi-Center Study Will Assess the Clinical Impact of Galleri® in addition to Currently Recommended Cancer Screenings in the Medicare Population GRAIL, LLC, a healthcare company...

Cytovale® Announces Commercial Launch of IntelliSep® Sepsis Test, the First-of-its-Kind Diagnostic Tool for Emergency Departments

Cytovale, a pioneering medical diagnostics company focused on advancing early detection technologies to diagnose fast-moving and immune-mediated diseases, announced the U.S. commercial launch of...

IDACIO® (adalimumab-aacf) Now Available in the United States

Fresenius Kabi announced the immediate availability in the U.S. of its citrate-free adalimumab biosimilar IDACIO® (adalimumab-aacf) for use in the treatment of chronic autoimmune diseases for all...

Micross CMS Center of Excellence, Crewe, UK Receives Nadcap Certification

Micross Components, Inc. ("Micross"), a leading global provider of mission-critical microelectronic components and services for high-reliability aerospace, defense, space and industrial applications, is proud...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics